Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4195462 | Annals of Medicine and Surgery | 2016 | 4 Pages |
Abstract
•A safety of major lung resection after the use of Bev remains controversial.•Is it really dangerous to perform major lung resection after the use of Bev for a lung tumor?•Our results provide reliable information regarding the operative safety.
Recent new drugs, such as bevacizumab (Bev), also result in a remarkable response. However, the safety of major lung resection after the use of Bev remains controversial. Is it really dangerous to perform major lung resection after the use of Bev for a lung tumor? In this report, we describe two patients who underwent surgery safely without fragile pathological findings of the vessels.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Hidetaka Uramoto, Yuki Nakajima, Hiroyasu Kinoshita,